MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Cognitive Side Effects to Initial Levodopa Exposure as a “Red Flag”: A Retrospective Study

    A. Huang, A. Wise, V. Shanker (New York, USA)

    Objective: To assess if presence of cognitive side effects during an initial levodopa trial suggests the ultimate diagnosis of atypical Parkinson (APD) vs Parkinson disease…
  • 2024 International Congress

    The Cats-and-Dogs Test Predicts Cognitive Impairment in Parkinson’s Disease in a Diverse Population

    KC. Dey, D. Mair, A. Zirra, E. Camboe, T. Zannat, S. Haque, RS. Weil, DA. Gallagher, C. Budu, T. Haque, S. Ali, N. Mukadam, A. Habib, AJ. Noyce, CR. Marshall, S. Waters (London, United Kingdom)

    Objective: To establish whether a visuoperceptual tool (the Cats-and-Dogs test) can predict cognitive impairment (CI) in people with Parkinson’s disease (PwP) in a diverse population.…
  • 2024 International Congress

    How Does Mild Cognitive Impairment in Parkinson’s Disease Affect Communication Abilities?

    F. Rodriguez-Porcel, T. Turner (Charleston, USA)

    Objective: We explored differences in communication abilities in people with Parkinson’s disease (PwP) with mild cognitive impairment (MCI) (PwP-MCI) and those with normal cognition (PwP-CN).…
  • 2024 International Congress

    Dissecting Neural Circuits Regulating Sleep State Transitions in a Mouse Model of Parkinson’s Disease

    P. Marcott, A. Nelson (San Francisco, USA)

    Objective: To examine sleep architecture in a commonly studied mouse model of Parkinson’s disease (PD) to better understand underlying circuit mechanisms of sleep disturbances in…
  • 2024 International Congress

    A Network Analysis shows How Impulsive-Compulsive Behaviors correlates with Levodopa-Induced Dyskinesia

    B. Veiga, C. Silva, S. Silva, R. Saba, H. Ferraz, V. Borges (São Paulo, Brazil)

    Objective: To study Impulsive Compulsive Behaviors (ICBs) and Levodopa-Induced Dyskinesias (LIDs) in Young Onset Parkinson's disease (YOPD) patients. Background: Parkinson's disease (PD) is a neurodegenerative…
  • 2024 International Congress

    Fatigue in Parkinson’s Disease: Prevalence and Risk Factors

    C. Falup-Pecurariu, I. Murasan, D. Rusu, B. Opritoiu, L. Ungureanu, L. Irincu, I. Despa, S. Diaconu (Brasov, Romania)

    Objective: To determine the prevalence of fatigue among people with PD (PwP) in comparison to the general population and to identify fatigue associated factors. Background:…
  • 2024 International Congress

    Exploring Supervised and Real-World Mobility in People with Parkinson’s Disease with and without Nocturnal Hypokinesia

    E. Bianchini, D. Rinaldi, S. Galli, M. Alborghetti, L. de Carolis, P. Petit, P. Pacilio, T. Milane, C. Hansen, FE. Pontieri, N. Vuillerme (Rome, Italy)

    Objective: To evaluate supervised and real-world mobility in people with Parkinson’s disease (PwPD) with and without nocturnal hypokinesia (NH). Background: Mobility impairment and NH are…
  • 2024 International Congress

    The effect of Diabetes Mellitus and Cardiovascular disease on Parkinson’s disease

    T. Abali, SN. Kibrit, Z. özdamar, İ. Köker, AV. Karacan, MK. Yekedüz, R. Yilmaz, FT. Eminoglu, MC. Akbostancı (Ankara, Turkey)

    Objective: To understand the impact of the comorbidities; namely Type 2 Diabetes Mellitus (DM) and/or cardiovascular disease (CVD) on the clinical features of Parkinson’s disease…
  • 2024 International Congress

    Subjective Sleep Quality and Pathological Sleepiness in Veterans with Parkinson’s Disease

    A. Sarwar (PEARLAND, USA)

    Objective: To determine the subjective sleep quality and its association with pathological sleepiness in Veterans with Parkinson's disease (PD). Background: Sleep quality issues and pathological…
  • 2024 International Congress

    Systematic Review and Meta-Analysis of Pesticide Exposure and the Risk of Parkinson’s Disease

    J. Cheong, ZHK. Goh, H. Frankland, S. Spearman, J. Steinmetz, A. Noyce (London, United Kingdom)

    Objective: This study aimed to investigate the association between exposure to pesticides and the risk of Parkinson’s disease (PD). Background: PD is the second most…
  • « Previous Page
  • 1
  • …
  • 87
  • 88
  • 89
  • 90
  • 91
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley